Y-Intercept (HK)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$877K Buy
+103,398
New +$688K 0.02% 1103
2025
Q4
Sell
-24,990
Closed -$193K 1979
2025
Q3
$193K Sell
24,990
-287,570
-92% -$2.24M ﹤0.01% 1474
2025
Q2
$2.72M Buy
+312,560
New +$2.27M 0.07% 466
2024
Q4
Sell
-16,580
Closed -$152K 1646
2024
Q3
$152K Buy
+16,580
New +$137K 0.01% 1194
2024
Q2
Sell
-40,536
Closed -$612K 1914
2024
Q1
$612K Sell
40,536
-15,740
-28% -$286K 0.05% 610
2023
Q4
$1.21M Buy
+56,276
New +$1.04M 0.11% 254
2023
Q3
Sell
-47,885
Closed -$1.21M 1579
2023
Q2
$1.21M Buy
+47,885
New +$1.21M 0.13% 228
2021
Q2
Sell
-10,913
Closed -$1.91M 892
2021
Q1
$1.91M Buy
+10,913
New +$2.53M 0.51% 32

Other funds holding TDOC

Y-Intercept (HK)'s TDOC Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Teladoc Health (TDOC) in Q2 2026: 103,398 shares worth $877K. The stake represents 0.02% of the portfolio and ranks #1103 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in TDOC as recently as Q3 2025.

Y-Intercept (HK) first reported a position in TDOC in Q1 2021 and has held it in 8 quarters since. The position peaked at $2.72M in Q2 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Y-Intercept (HK) held 103,398 shares of Teladoc Health worth $877K as of Q2 2026.
  • Teladoc Health was a new Y-Intercept (HK) position in Q2 2026.
  • Teladoc Health made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1103 holding.
  • Y-Intercept (HK) first reported a position in Teladoc Health in Q1 2021 and has held it in 8 quarters since.
  • Y-Intercept (HK)'s Teladoc Health position peaked at $2.72M in Q2 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.